Resveratrol-induced inhibition of insulin secretion from rat pancreatic islets: Evidence for pivotal role of metabolic disturbances

American Journal of Physiology - Endocrinology and Metabolism

Volumn 293, Issue 4, 2007, Pages

  Szkudelski, Tomasz ^a  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Amplifying pathway; Glucose oxidation; Lactate

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIAZOXIDE; ESTROGEN RECEPTOR; GLUCOSE; INSULIN; LACTIC ACID; LEUCINE; POTASSIUM; PROTEIN KINASE C; RESVERATROL; VOLTAGE DEPENDENT ANION CHANNEL;

ANAEROBIC METABOLISM; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL CULTURE; CELL ISOLATION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; GLUCOSE METABOLISM; GLUCOSE OXIDATION; INSULIN RELEASE; MALE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANIMALS; CARRIER PROTEINS; CELL SURVIVAL; ESTRADIOL; FORSKOLIN; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; METABOLIC NETWORKS AND PATHWAYS; RATS; RATS, WISTAR; RECEPTORS, ESTROGEN; STILBENES; TETRADECANOYLPHORBOL ACETATE;

EID: 35148897270     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00564.2006     Document Type: Article

References (50)

1. Altnan SA, Randers L, Rao G. Comparison of trypan blue dye exclusion and fluorometric assay for mammalian cell viability determinations. Biotechnol Prog 9: 671-674, 1993.
2. Antinozzi PA, Ishihara H, Newgard CB, Wollheim CB. Mitochondrial metabolism sets the maximal limit of fuel-stimulated insulin secretion in a model pancreatic beta cell: a survey of four fuel secretagogues. J Biol Chem 277: 11746-11755, 2002.
3. Atten MJ, Attar BM, Milson T, Holian O. Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism. Biochem Pharmacol 62: 1423-1432, 2001.
4. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141: 3657-3667, 2000.
5. Buluc M, Demirel-Yilmaz E. Resveratrol decreases calcium sensitivity of vascular smooth muscle and enhances cytosolic calcium increase in endothelium. Vascul Pharmacol 44: 231-237, 2006.
6. Campos-Toimil M, Elies J, Orallo F. Trans- and cis-resveratrol increase cytoplasmic calcium levels in A7r5 vascular smooth muscle cells. Mol Nutr Food Res 49: 396-404, 2005.
7. Chan WH. Effect of resveratrol on high glucose-induced stress in human leukemia K562 cells. J Cell Biochem 94: 1267-1279, 2005.
8. Das S, Alagappan VKT, Bagchi D, Sharma HS, Maulik N, Das DK. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption. A potential mechanism for resveratrol preconditioning of the heart. Vasc Pharmacol 42: 281-289, 2005.
9. Dobrydneva Y, Williams RL, Blackmore PF. trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. Br J Pharmacol 128: 149-157, 1999.
10. Duchen MR, Smith PA, Ashcroft FM. Substrate-dependent changes in mitochondrial function, intracellular free calcium concentration and membrane channels in pancreatic beta-cells. Biochem J 294: 35-42, 1993.
11. El-Mowafy AM, Alkhalaf M. Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 24: 869-873, 2003.
12. Everse J. Enzymic determination of lactic acid. Methods Enzymol 41: 41-44, 1975.
13. + channels in mouse B cells. J Clin Invest 91: 871-880, 1993.
14. + channels in mouse B cells. J Clin Invest 89: 1288-1295, 1992.
15. Hambrock A, de Oliveira Franz CB, Hiller S, Grenz A, Ackermann S, Schulze DU, Drews G, Osswald H. Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner. J Biol Chem 282: 3347-3356, 2007.
16. Hansen JB, Arkhammar PO, Bodvarsdottir TB, Wahl P. Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders. Curr Med Chem 11: 1595-1615, 2004.
17. Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49: 1751-1760, 2000.
18. Hill DJ, Petrik J, Arany E, McDonald TJ, Delovitch TL. Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice. J Endocrinol 161: 153-165, 1999.
19. Holmes-McNary M, Baldwin AS Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res 60: 3477-3483, 2000.
20. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 47: 549-555, 2000.
21. Ingham JM. 3,5,4′-Trihydroxystilbene as a phytoalexin from groundnuts (Arichis hypogaea). Phytochemistry 15: 1791-1793, 1976.
22. Janjic D, Wollheim CB. Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia 35: 482-485, 1992.
23. Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK, Zhao L, Brey DM, Keynton RS. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 280: 7460-7468, 2005.
24. + channel-independent phenomenon. Diabetes 51: 29-32, 2002.
25. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39, 1967.
26. Landcake P, Price RJ. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol 9: 77-86, 1976.
27. Lawinski M, Sledzinski Z, Kubasik-Juraniec J, Spodnik JH, Wozniak M, Boguslawski W. Does resveratrol prevent free radical-induced acute pancreatitis? Pancreas 31: 43-47, 2005.
28. Li ZD, Ma QY, Wang CA. Effect of resveratrol on pancreatic oxygen free radicals in rats with severe acute pancreatitis. World J Gastroenterol 12: 137-140, 2006.
29. Liew R, Stagg MA, MacLeod KT, Collins P. The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes. Eur J Pharmacol 5: 1-8, 2005.
30. Ma ZH, Ma QY, Wang LC, Sha HC, Wu SL, Zhang M. Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis. Inflamm Res 54: 522-527, 2005.
31. MacDonald MJ. High content of mitochondrial glycerol-3-phosphate dehydrogenase in pancreatic islets and its inhibition by diazoxide. J Biol Chem 256: 8287-8290, 1981.
32. Meng Y, Ma QY, Kou XP, Xu J. Effect of resveratrol on activation of nuclear factor kappa-B and inflammatory factors in rat model of acute pancreatitis. World J Gastroenterol 28: 525-528, 2005.
33. Miller NJ, Rice-Evans CA. Antioxidant activity of resveratrol in red wine (Abstract). Clin Chem 41: 1789, 1995.
34. Noda M, Yamashita S, Takahashi N, Eto K, Shen LM, Izumi K, Daniel S, Tsubamoto Y, Nemoto T, Iino M, Kasai H, Sharp GW, Kadowaki T. Switch to anaerobic glucose metabolism with NADH accumulation in the beta-cell model of mitochondrial diabetes. Characteristics of betaHC9 cells deficient in mitochondrial DNA transcription. J Biol Chem 277: 41817-41826, 2002.
35. Rabuazzo AM, Buscema M, Caltabiano V, Anello M, Patané G, Vigneri R, Purrello F. Interleukin-1β- inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway. Diabetologia 38: 779-784, 1995.
36. Rustenbeck I. Desensitization of insulin secretion. Biochem Pharmacol 63: 1921-1935, 2002.
37. Rutter GA. Nutrient-secretion coupling in the pancreatic islet beta-cell: recent advances. Mol Aspects Med 22: 247-284, 2001.
38. Sang-Hoon L, Hyun-Young L, So-Yeon K, In-Kyu L, Dae-Kyu S. Enhancing effect of taurine on glucose response in UCP2-overexpressing beta cells. Diabetes Res Clin Pract 66: 69-74, 2004.
39. Sekine N, Cirulli V, Regazzi R, Brown LJ, Gine E, Tamarit-Rodriguez J, Girotti M, Marie S, MacDonald J, Wollheim CB. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing. J Biol Chem 269: 4895-4902, 1994.
40. Sharma S, Anjaneyulu M, Kulkarni SK, Chopra K. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 76: 69-75, 2006.
41. Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 43: 49-52, 1992.
42. Slater SJ, Seiz JL, Cook AC, Stagliano BA, Buzas CJ. Inhibition of protein kinase C by resveratrol. Biochim Biophys Acta 20: 59-69, 2003.
43. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem 30: 91-113, 1997.
44. Su HC, Hung LM, Chen JK. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 290: E1339-E1346, 2006.
45. Szabolcs A, Varga IS, Varga C, Berko A, Kaszaki J, Letoha T, Tiszlavicz L, Sari R, Lonovics J, Takacs T. Beneficial effect of resveratrol on cholecystokinin-induced experimental pancreatitis. Eur J Pharmacol 532: 187-193, 2006.
46. Szkudelski T. Resveratrol inhibits insulin secretion from rat pancreatic islets. Eur J Pharmacol 552: 176-181, 2006.
47. Tsai SH, Lin-Shiau SY, Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NF-kappaB in macrophages by resveratrol. Br J Pharmacol 126: 673-680, 1999.
48. 2+. J Gen Physiol 124: 653-662, 2004.
49. Zheng J, Ramirez VD. Inhibition of mitochondrial proton F0F1-ATPase/ ATP synthase by polyphenolic phytochemicals. Br J Pharmacol 130: 1115-1123, 2000.
50. Zini R, Morin C, Bertelli A, Bertelli AA, Tillement JP. Resveratrol-induced limitation of dysfunction of mitochondria isolated from rat brain in an anoxia-reoxygenation model. Life Sci 71: 3091-3108, 2002.